Table 6.

The relationships of anxiety scores with menstrual characteristics of the study population after COVID-19 via multiple linear regression.

Menstrual characteristics	B	95% CI	SE	p values
Cycle length (days)	−0.005	−0.040–0.029	0.017	0.759
Bleeding days	0.008	−0.393–0.409	0.204	0.970
Heavy bleeding days number	0.091	−0.175–0.358	0.135	0.499
Pads per day	0.230	−0.003–0.463	0.119	0.050*
Pads per night	−0.256	−1.013–0.501	0.385	0.507
Bleeding amount
Mild	0.897	−0.867–2.661	0.897	0.318
Moderate	−2.619	−3.940– −1.298	0.672	> 0.001***
Heavy	25.613	1.132–4.094	0.753	> 0.001***
Indicators for heavy menstrual bleeding
Double protection	−0.943	−2.315–0.428	0.698	0.177
Night leak	1.050	−0.304–2.404	0.688	0.128
Clots	0.767	−0.874–2.408	0.835	0.359
Anemia	−0.696	−2.212–0.820	0.771	0.368
Symptoms of menstruation
Nausea and/or vomiting	1.706	0.322–3.090	0.704	0.016*
Consumption and/or diarrhea	−0.762	−2.506–0.983	0.887	0.319
Flatulence	−0.145	−2.643–2.353	1.271	0.909
Breast pain	0.277	−1.277–1.830	0.790	0.726
Fatigue	−3.652	−8.070–0.765	2.247	0.105
Appetite change	1.519	−0.776–3.815	1.167	0.194
Headache	0.54	−1.282–1.989	0.832	0.671
Urgency	1.837	0.424–3.249	0.718	0.011*
Mood swing	−1.301	−4.316–1.714	1.533	0.397
Anger	0.083	−2.455–2.620	1.291	0.949
Acne	0.824	−13.94–3.042	1.128	0.466
Irregular bleeding between period	−0.505	−1.870–0.860	0.694	0.467
Light or absent period	0.070	−1.308–1.448	0.701	0.924
Six-month absence	3.845	0.77–6.912	1.560	0.014*
Menstrual disorders treatment
Unknown	−6.837	−13.406–−0.268	3.341	0.040*
Hormonal	0.922	−3.509–5.353	2.254	0.683
Herbs	−1.334	−2.850–0.182	0.771	0.085
Contraception	1.799	−1.774–5.372-	1.817	0.323
Surgery	3.251	6.060–12.561	4.735	0.493
Others	3.486	1.431–5.540	1.045	0 > .001***

CI: confidence interval; SE: standard error.

^*p ⩽ 0.05.

^***p ⩽ 0.001.